New Two-Drug approach tested to fight bone loss after spinal injury
NCT ID NCT04708886
Summary
This study tested a two-year treatment plan to control bone loss in women with spinal cord injury and osteoporosis. Twelve participants received monthly injections of romosozumab for the first year, followed by weekly pills of alendronate for the second year, to see if this sequence could build and then maintain bone strength. The goal was to see if this approach was safe and effective for this specific group of patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern University Feinberg School of Medicine
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.